Works matching IS 09395555 AND DT 2023 AND VI 102 AND IP 4
Results: 35
Tocilizumab, an IL6-receptor antibody, proved effective as adjuvant therapy for cytokine storm induced by severe infection in patients with hematologic malignancy.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 4, p. 961, doi. 10.1007/s00277-023-05146-0
- By:
- Publication type:
- Article
Neonatal hematological parameters: the translational aspect of developmental hematopoiesis.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 4, p. 707, doi. 10.1007/s00277-023-05144-2
- By:
- Publication type:
- Article
The prognostic value of patient-reported outcomes in allogeneic hematopoietic stem cell transplantation: exploratory analysis of a randomized nutrition intervention trial.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 4, p. 927, doi. 10.1007/s00277-023-05149-x
- By:
- Publication type:
- Article
COVID-19 in patients with chronic lymphocytic leukemia: a multicenter analysis by the Czech CLL study group.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 4, p. 811, doi. 10.1007/s00277-023-05147-z
- By:
- Publication type:
- Article
High susceptibility of febrile neutropenia in Japanese patients receiving venetoclax plus azacitidine therapy for acute myeloid leukemia.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 4, p. 971, doi. 10.1007/s00277-023-05143-3
- By:
- Publication type:
- Article
Humoral response to mRNA-based COVID-19 vaccine and booster effect of a third dose in patients with mature T cell and NK-cell neoplasms.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 4, p. 819, doi. 10.1007/s00277-023-05142-4
- By:
- Publication type:
- Article
Real-world outcomes of adult patients with acute lymphoblastic leukemia treated with a modified CALGB 10102 regimen.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 4, p. 897, doi. 10.1007/s00277-023-05141-5
- By:
- Publication type:
- Article
Prognostic value of interim <sup>18</sup>F-FDG PET/CT in adult follicular lymphoma treated with R-CHOP.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 4, p. 795, doi. 10.1007/s00277-023-05138-0
- By:
- Publication type:
- Article
Analysis of hematologic adverse events reported to a national surveillance system following COVID-19 bivalent booster vaccination.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 4, p. 955, doi. 10.1007/s00277-023-05136-2
- By:
- Publication type:
- Article
ERCC6L2-related disease: a novel entity of bone marrow failure disorder with high risk of clonal evolution.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 4, p. 699, doi. 10.1007/s00277-023-05128-2
- By:
- Publication type:
- Article
Impact of age on hospitalization and outcomes post allogeneic hematopoietic cell transplantation outcome, a single center experience.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 4, p. 917, doi. 10.1007/s00277-023-05135-3
- By:
- Publication type:
- Article
Risks and outcomes of hospitalizations in patients with chronic lymphocytic leukemia admitted with immune thrombocytopenia: an analysis of the National Inpatient Sample Database.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 4, p. 889, doi. 10.1007/s00277-023-05133-5
- By:
- Publication type:
- Article
Serum cytokine pattern in children with hemophagocytic lymphohistiocytosis.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 4, p. 729, doi. 10.1007/s00277-023-05132-6
- By:
- Publication type:
- Article
Long-term clinical outcomes of gastric mucosa-associated lymphoid tissue lymphoma in real-world experience.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 4, p. 877, doi. 10.1007/s00277-023-05130-8
- By:
- Publication type:
- Article
Impact of gemtuzumab ozogamicin consolidation on hematopoietic stem cells (HSCs) mobilization in AML: analysis of 20 patients.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 4, p. 769, doi. 10.1007/s00277-023-05129-1
- By:
- Publication type:
- Article
Pain: a neglected symptom in hemophilia.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 4, p. 947, doi. 10.1007/s00277-023-05134-4
- By:
- Publication type:
- Article
How I manage anemia related to myelofibrosis and its treatment regimens.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 4, p. 689, doi. 10.1007/s00277-023-05126-4
- By:
- Publication type:
- Article
Improved Vδ2<sup>+</sup> T cells recovery correlates to reduced incidences of mortality and relapse in acute myeloid leukemia after hematopoietic transplantation.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 4, p. 937, doi. 10.1007/s00277-023-05125-5
- By:
- Publication type:
- Article
Maternal factors associated with iron deficiency without anaemia in early pregnancy: ECLIPSES study.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 4, p. 741, doi. 10.1007/s00277-023-05123-7
- By:
- Publication type:
- Article
Value of the FDP/FIB ratio in predicting early severe bleeding events in patients with newly diagnosed acute promyelocytic leukemia.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 4, p. 787, doi. 10.1007/s00277-023-05122-8
- By:
- Publication type:
- Article
Early leukoencephalopathy during daratumumab treatment in a patient with multiple myeloma.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 4, p. 967, doi. 10.1007/s00277-023-05120-w
- By:
- Publication type:
- Article
Benefits of dexamethasone on early outcomes in patients with acute myeloid leukemia with hyperleukocytosis: a propensity score matched analysis.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 4, p. 761, doi. 10.1007/s00277-023-05119-3
- By:
- Publication type:
- Article
Prognostic factors for patients with hematologic malignancies admitted to the intensive care unit: is allogeneic transplantation still a risk factor?
- Published in:
- Annals of Hematology, 2023, v. 102, n. 4, p. 907, doi. 10.1007/s00277-023-05118-4
- By:
- Publication type:
- Article
Low T3 syndrome as a predictor of poor outcomes in patients with follicular lymphoma.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 4, p. 851, doi. 10.1007/s00277-023-05117-5
- By:
- Publication type:
- Article
Characteristics of inpatients with newly diagnosed multiple myeloma in hematology, nephrology, and orthopedic departments.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 4, p. 801, doi. 10.1007/s00277-023-05115-7
- By:
- Publication type:
- Article
Use of thrombopoietin receptor agonists in adults with immune thrombocytopenia: a systematic review and Central European expert consensus.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 4, p. 715, doi. 10.1007/s00277-023-05114-8
- By:
- Publication type:
- Article
Ibrutinib in relapsed/refractory patients with Waldenström macroglobulinemia: a real-life, retrospective study on behalf of the "RTL" (regional Tuscan lymphoma network).
- Published in:
- Annals of Hematology, 2023, v. 102, n. 4, p. 841, doi. 10.1007/s00277-023-05113-9
- By:
- Publication type:
- Article
Clonal evolution analysis of a rare acute promyelocytic leukemia patient transforming from essential thrombocythemia.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 4, p. 981, doi. 10.1007/s00277-023-05112-w
- By:
- Publication type:
- Article
Amsacrine-based induction therapy in AML patients with cardiac comorbidities: a retrospective single-center analysis.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 4, p. 755, doi. 10.1007/s00277-023-05111-x
- By:
- Publication type:
- Article
Combination venetoclax and olverembatinib (HQP1351) as a successful therapeutic strategy for relapsed/refractory (R/R) mixed-phenotype blast phase of chronic myeloid leukemia.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 4, p. 973, doi. 10.1007/s00277-023-05110-y
- By:
- Publication type:
- Article
Venetoclax plus azacitidine compared with intensive chemotherapy as induction for patients with acute myeloid leukemia: retrospective analysis of an electronic medical record database in the United States.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 4, p. 749, doi. 10.1007/s00277-023-05109-5
- By:
- Publication type:
- Article
Molecular genetics and management of world health organization defined atypical chronic myeloid leukemia.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 4, p. 777, doi. 10.1007/s00277-023-05106-8
- By:
- Publication type:
- Article
Daratumumab plus bortezomib, cyclophosphamide, and dexamethasone in Asian patients with newly diagnosed AL amyloidosis: subgroup analysis of ANDROMEDA.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 4, p. 863, doi. 10.1007/s00277-023-05090-z
- By:
- Publication type:
- Article
Rare forms of idiopathic multicentric Castleman disease presenting with intrahepatic cholestatic jaundice successfully treated with the bortezomib-based regimen: two case reports.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 4, p. 977, doi. 10.1007/s00277-022-05066-5
- By:
- Publication type:
- Article
Central nervous system involvement at initial diagnosis of extranodal NK/T-cell lymphoma: a retrospective study of a consecutive 12-year case series.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 4, p. 829, doi. 10.1007/s00277-022-05065-6
- By:
- Publication type:
- Article